国产精品视频一区二区三区四,亚洲av美洲av综合av,99国内精品久久久久久久,欧美电影一区二区三区电影

官方微信|手機版

產(chǎn)品展廳

產(chǎn)品求購企業(yè)資訊會展

發(fā)布詢價單

化工儀器網(wǎng)>產(chǎn)品展廳>化工原料>生物化工醫(yī)藥>原料藥> S80074

S80074

具體成交價以合同協(xié)議為準

聯(lián)系方式:何小姐查看聯(lián)系方式

聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!


上海源葉生物科技有限公司是一家專門從事生物技術相關產(chǎn)品研發(fā)和銷售的綜合性生命科學公司,在全體員工的不懈努力和廣大客戶的大力支持下,公司迅速成長為一家擁有生物試劑部、實驗及醫(yī)用耗材部、生命科學儀器部以及技術服務部等部門的高新技術企業(yè)。





生物試劑,ELISA試劑盒,對照品,標準品,培養(yǎng)基,透析袋,病理科耗材,實驗室耗材

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
  • 靶點: LTD4
  • 體內(nèi)研究: Zafirlukast is a peptidyl leukotriene antagonist and inhibitor of LTD4. After 13 weeks of exposure, the yield of lung tumors is significantly decreased by both dose levels of Zafirlukast (270 and 540 mg/kg), the high dose of Zileuton (1200 mg/kg), and the combinations containing 600 mg/kg Zileuton with either Zafirlukast or MK-866. The efficacy of the combination containing Zileuton and Zafirlukast to prevent lung tumors is not significantly different from the efficacy of either inhibitor administered alone. Although when administered alone at the dose level in their combination, neither Zileuton or MK-886 prevents lung tumors; the combination containing them does significantly prevent tumors. In contrast, the combination containing Zafirlukast and MK-886 does not reduce the yield of tumors, whereas Zafirlukast administered alone does significantly reduce the yield of tumors
  • 參考文獻:
    1. Finnerty JP, et al. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):746-9. 2. Gunning WT, et al. Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice. Cancer Res. 2002 Aug 1;62(15):4199-201. 3. Lei C, et al. Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM). Int Immunopharmacol. 2019;68:68-73.
  • 溶解度: DMSO  :  100  mg/mL  (173.71  mM;  Need  ultrasonic)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.737 ml 8.685 ml 17.371 ml
    5 mM 0.347 ml 1.737 ml 3.474 ml
    10 mM 0.174 ml 0.869 ml 1.737 ml
    50 mM 0.035 ml 0.174 ml 0.347 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的性,僅供客戶參考交流研究之用。


化工儀器網(wǎng)

采購商登錄
記住賬號    找回密碼
沒有賬號?免費注冊

提示

×

*您想獲取產(chǎn)品的資料:

以上可多選,勾選其他,可自行輸入要求

個人信息:

溫馨提示

該企業(yè)已關閉在線交流功能

道孚县| 将乐县| 富民县| 西充县| 陆良县| 青州市| 宣化县| 宝鸡市| 林州市| 和硕县| 漯河市| 延安市| 涞水县| 洪泽县| 鄱阳县| 马山县| 雅江县| 嫩江县| 桦甸市| 阜阳市| 平和县| 南澳县| 上高县| 龙岩市| 平定县| 冕宁县| 南召县| 临江市| 蒙自县| 墨竹工卡县| 靖江市| 巴楚县| 邵武市| 天水市| 波密县| 邯郸市| 修文县| 怀仁县| 来安县| 兴业县| 拜城县|